Content
@
https://warpcast.com/~/channel/longevity
0 reply
0 recast
0 reaction
Omar
@dromar.eth
The battle of digital longevity/healthspan platforms will likely come down to UI that keeps patients interested once they have exhausted the novelty of it all. Incentives will be everything.
3 replies
0 recast
2 reactions
kagami 🎩
@kagami
i think at some point we may see telehealth platforms (ex: ro, hims, etc) may roll up digital longevity/healthspan platforms to provide additional services/value to existing customers + upsell generic/off-brand medication or supplements to current users. i think this would also be a really interesting offering for menopause telehealth companies as women age out at 65+ but may still be interested/care about longevity. would be another way to monetize a patient where there’s a long term, trusting relationship
1 reply
0 recast
1 reaction
Omar
@dromar.eth
That likely will be the way to go for most. Especially for women as so much healthspan benefits reside in optimizing hormonal management during pre/peri/post menopause. Hone Health is one that offers that right now. Bigger question of this though will be how patients can be personalized. Especially with hormonal therapies that both for men and women carry cardiac and other risks if mismanaged. But overall telehealth is the way the shift is happening.
1 reply
0 recast
1 reaction
kagami 🎩
@kagami
i think “personalized” is currently a marketing term vs actual customized treatment based on a patient. telehealth companies may optimize towards minimizing appointments with dr/np/rn and maximizing immediate treatment effectiveness. the incentives aren’t aligned for customized treatment with careful management. immediately treating symptoms may result is titrating down vs titrating up to prevent a patient from churning because initial treatment isn’t effective as quickly as they’d like. this isn’t binary and the initial dosage may push the upper limit of recommended but it’s different from starting at the lowest dose and moving up. telehealth also leans heavily on async care via surveys to screen in/out patients to reduce costs of medical professionals. and a lack of unified medical records allows patients to obtain multiple prescriptions from different platforms. i think for something closer to personalization dpc or working with a pcp is still necessary
0 reply
0 recast
0 reaction
